Treatment of Hodgkin's disease: The Swedish national care programme experience

被引:29
作者
Glimelius, B
Enblad, G
Kalkner, M
Gustavsson, A
Jakobsson, M
Branehog, I
Lenner, P
Bjorkholm, M
机构
[1] Department of Oncology, Regional Oncological Centre, Uppsala University, Uppsala
[2] Department of Oncology, Regional Oncological Centre, University Hospital, Lund
[3] Department of Oncology, Regional Oncological Centre, Linköping University, Linköping
[4] Department of Oncology, Regional Oncological Centre, Gothenburg University, Stockholm
[5] Department of Oncology, Regional Oncological Centre, Umeå University, Umeå
[6] Department of Medicine, Karolinska Hospital and Institute, Stockholm
[7] Department of Oncology, Akademiska Sjukhuset
关键词
Hodgkin's disease; national care programme; elderly patients; chemotherapy; radiotherapy;
D O I
10.3109/10428199609067582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since 1985 a Swedish National Care Programme has provided tailored principles for the diagnosis, staging, treatment and follow-up of patients with Hodgkin's disease (HD). This report gives the rationale behind the recommendations and presents treatment results for 648 patients diagnosed between 1985 and 1989 after a median follow-up of 70 months. Two hundred and twenty-nine (35%) patients were over 60 years of age. Treatment results for patients below 60 years of age in early and intermediate stages were favourable, provided the recommendations were followed. In advanced stages, the outcome was inferior in patients with CS IIB bulky disease and stage IVB. The prognosis of elderly patients remains poor, although it is too early to evaluate any impact of revisions made in 1989, The tailored principles, which usually entail less staging and/or treatment than is generally the case in the early and intermediate stages, produced favourable results when applied to an unselected group of patients with HD. Only minor changes were made in the recommendations during the 1994 revision.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 50 条
  • [21] Late Effects of Hodgkin's Disease and Its Treatment
    Ng, Andrea K.
    Mauch, Peter M.
    CANCER JOURNAL, 2009, 15 (02) : 164 - 168
  • [22] Hodgkin's disease: The next decade
    Hagemeister, FB
    LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) : 53 - 61
  • [23] Historical review of Hodgkin's disease
    Bonadonna, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 504 - 511
  • [24] Breast Cancer Following Hodgkin's Disease: The Experience of the University of Florence
    Meattini, Icro
    Livi, Lorenzo
    Saieva, Calogero
    Marrazzo, Livia
    Rampini, Andrea
    Iermano, Carmine
    Papi, Maria Grazia
    Detti, Beatrice
    Scoccianti, Silvia
    Biti, Giampaolo
    BREAST JOURNAL, 2010, 16 (03) : 290 - 296
  • [25] Pathogenese und Therapie des Hodgkin-LymphomsPathogenesis and treatment of Hodgkin’s disease
    Hans Tesch
    Heribert Bohlen
    Jürgen Wolf
    Andreas Engert
    Medizinische Klinik, 1998, 93 : 82 - 90
  • [26] Second malignancies following treatment of Hodgkin's disease: the Freiburg patients 1940 to 1991
    Slanina, J
    Heinemann, F
    Henne, K
    Moog, G
    Frommhold, H
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (04) : 154 - 161
  • [27] Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease
    Spector, N
    Costa, MA
    Morais, JC
    Biasoli, I
    Solza, C
    Gaui, MD
    Ferreira, CG
    Portugal, RD
    Loureiro, M
    Nucci, M
    Pulcheri, W
    ONCOLOGY REPORTS, 2002, 9 (02) : 439 - 442
  • [28] Early occurrence of a thyroid carcinoma in a patient who developed Graves' disease after treatment for Hodgkin's disease
    Belfiore, A
    Pellegriti, G
    Milone, G
    Vigneri, G
    Gangemi, P
    Fiumara, A
    Vigneri, R
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (11) : 869 - 871
  • [29] Late pulmonary toxicity after treatment for Hodgkin's disease
    Villani, F
    De Maria, P
    Bonfante, V
    Viviani, S
    Laffranchi, A
    Dell'Oca, I
    Dirusso, A
    Zanini, M
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4739 - 4742
  • [30] Treatment of childhood Hodgkin's disease with ABVD without radiotherapy
    Behrendt, H
    Brinkhuis, M
    VanLeeuwen, EF
    MEDICAL AND PEDIATRIC ONCOLOGY, 1996, 26 (04): : 244 - 248